Modeling neutralization kinetics of HIV by broadly neutralizing monoclonal antibodies in genital secretions coating the cervicovaginal mucosa.
Eliciting broadly neutralizing antibodies (bnAb) in cervicovaginal mucus (CVM) represents a promising "first line of defense" strategy to reduce vaginal HIV transmission. However, it remains unclear what levels of bnAb must be present in CVM to effectively reduce infection. We approached t...
Main Authors: | Scott A McKinley, Alex Chen, Feng Shi, Simi Wang, Peter J Mucha, M Gregory Forest, Samuel K Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4072659?pdf=render |
Similar Items
-
Modeling of Virion Collisions in Cervicovaginal Mucus Reveals Limits on Agglutination as the Protective Mechanism of Secretory Immunoglobulin A.
by: Alex Chen, et al.
Published: (2015-01-01) -
Pharmacokinetics and immunogenicity of broadly neutralizing HIV monoclonal antibodies in macaques.
by: Yvonne Rosenberg, et al.
Published: (2015-01-01) -
Epitope mapping of broadly neutralizing HIV-2 human monoclonal antibodies.
by: Kong, R, et al.
Published: (2012) -
Human monoclonal antibodies broadly neutralizing against influenza B virus.
by: Mayo Yasugi, et al.
Published: (2013-02-01) -
Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
by: Hae Li Ko, et al.
Published: (2023-12-01)